ES2115975T3 - Derivados de triariletileno utilizados terapeuticamente. - Google Patents
Derivados de triariletileno utilizados terapeuticamente.Info
- Publication number
- ES2115975T3 ES2115975T3 ES94927182T ES94927182T ES2115975T3 ES 2115975 T3 ES2115975 T3 ES 2115975T3 ES 94927182 T ES94927182 T ES 94927182T ES 94927182 T ES94927182 T ES 94927182T ES 2115975 T3 ES2115975 T3 ES 2115975T3
- Authority
- ES
- Spain
- Prior art keywords
- used therapeutically
- derivatives used
- triarylethylene
- triarylethylene derivatives
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A NUEVOS DERIVADOS DE TRIARILETILENO QUE CON UTILES COMO AGENTES ANTINEOPLASICOS, AGENTES ANTIATEROSCLEROTICOS Y AGENTES HIPOCOLESTEROLEMICOS.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12661493A | 1993-09-24 | 1993-09-24 | |
| US08/259,797 US5525633A (en) | 1993-09-24 | 1994-06-15 | Triaryl-ethylene derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2115975T3 true ES2115975T3 (es) | 1998-07-01 |
Family
ID=26824862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94927182T Expired - Lifetime ES2115975T3 (es) | 1993-09-24 | 1994-08-19 | Derivados de triariletileno utilizados terapeuticamente. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5684004A (es) |
| EP (1) | EP0720597B1 (es) |
| JP (1) | JPH09503761A (es) |
| CN (1) | CN1131415A (es) |
| AT (1) | ATE165594T1 (es) |
| AU (1) | AU678535B2 (es) |
| CA (1) | CA2171728C (es) |
| DE (1) | DE69409961T2 (es) |
| DK (1) | DK0720597T3 (es) |
| ES (1) | ES2115975T3 (es) |
| FI (1) | FI961339A7 (es) |
| HU (1) | HUT75933A (es) |
| IL (1) | IL111018A0 (es) |
| NO (1) | NO306292B1 (es) |
| NZ (1) | NZ273433A (es) |
| PL (1) | PL177833B1 (es) |
| WO (1) | WO1995008528A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002322720B2 (en) | 2001-07-25 | 2008-11-13 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| CN102379684B (zh) | 2005-04-28 | 2014-11-19 | 普罗透斯数字保健公司 | 药物信息系统 |
| KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료 |
| EP2398500B1 (en) | 2009-02-20 | 2019-03-13 | 2-BBB Medicines B.V. | Glutathione-based drug delivery system |
| ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1099093A (en) * | 1965-09-03 | 1968-01-17 | Ici Ltd | Alkene derivatives |
| EP0002097B1 (en) * | 1977-08-22 | 1981-08-05 | Imperial Chemical Industries Plc | Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
-
1994
- 1994-08-19 HU HU9600727A patent/HUT75933A/hu unknown
- 1994-08-19 PL PL94313594A patent/PL177833B1/pl unknown
- 1994-08-19 DK DK94927182T patent/DK0720597T3/da active
- 1994-08-19 EP EP94927182A patent/EP0720597B1/en not_active Expired - Lifetime
- 1994-08-19 JP JP7509757A patent/JPH09503761A/ja not_active Ceased
- 1994-08-19 FI FI961339A patent/FI961339A7/fi not_active IP Right Cessation
- 1994-08-19 AU AU76707/94A patent/AU678535B2/en not_active Ceased
- 1994-08-19 CN CN94193479A patent/CN1131415A/zh active Pending
- 1994-08-19 NZ NZ273433A patent/NZ273433A/en unknown
- 1994-08-19 AT AT94927182T patent/ATE165594T1/de not_active IP Right Cessation
- 1994-08-19 WO PCT/US1994/009314 patent/WO1995008528A1/en not_active Ceased
- 1994-08-19 DE DE69409961T patent/DE69409961T2/de not_active Expired - Fee Related
- 1994-08-19 ES ES94927182T patent/ES2115975T3/es not_active Expired - Lifetime
- 1994-08-19 CA CA002171728A patent/CA2171728C/en not_active Expired - Fee Related
- 1994-09-21 IL IL11101894A patent/IL111018A0/xx unknown
-
1995
- 1995-06-05 US US08/463,792 patent/US5684004A/en not_active Expired - Fee Related
-
1996
- 1996-03-25 NO NO961204A patent/NO306292B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL313594A1 (en) | 1996-07-08 |
| NO961204D0 (no) | 1996-03-25 |
| US5684004A (en) | 1997-11-04 |
| DK0720597T3 (da) | 1998-10-07 |
| EP0720597B1 (en) | 1998-04-29 |
| NZ273433A (en) | 1997-11-24 |
| NO961204L (no) | 1996-03-25 |
| FI961339A0 (fi) | 1996-03-22 |
| CN1131415A (zh) | 1996-09-18 |
| DE69409961D1 (de) | 1998-06-04 |
| CA2171728A1 (en) | 1995-03-30 |
| NO306292B1 (no) | 1999-10-18 |
| WO1995008528A1 (en) | 1995-03-30 |
| JPH09503761A (ja) | 1997-04-15 |
| AU678535B2 (en) | 1997-05-29 |
| AU7670794A (en) | 1995-04-10 |
| PL177833B1 (pl) | 2000-01-31 |
| FI961339L (fi) | 1996-03-22 |
| CA2171728C (en) | 2001-11-13 |
| IL111018A0 (en) | 1994-11-28 |
| EP0720597A1 (en) | 1996-07-10 |
| DE69409961T2 (de) | 1998-09-10 |
| HUT75933A (en) | 1997-05-28 |
| FI961339A7 (fi) | 1996-03-22 |
| ATE165594T1 (de) | 1998-05-15 |
| HU9600727D0 (en) | 1996-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HN1997000126A (es) | Derivados de indazol | |
| HN1998000086A (es) | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. | |
| HN1998000124A (es) | Terapia de combinacion | |
| HN1998000132A (es) | Combinaciones terapeuticas | |
| HN1998000168A (es) | Derivados de la tienapirimidina y de la tienapiridina utiles como agentes anticancerigenos. | |
| HN1997000023A (es) | Derivados de lactama | |
| HN1998000011A (es) | Derivados de acidos arilsulfonilaminohidroxamicos | |
| HN1997000012A (es) | Derivados de triazol utiles en terapia. | |
| HN1998000036A (es) | Compuesto de pirazina | |
| HN1999000125A (es) | Nuevos derivados sustituidos del pirazol | |
| HN1999000066A (es) | Formulaciones farmaceuticas | |
| HN1998000139A (es) | Pirimidin-4-ona y pirimidin-4-tiona novedosas como funguicidas | |
| ES2098140T3 (es) | Liosferas que contienen gonadotropina. | |
| HN1997000146A (es) | Derivados de pirimidina biciclica condensada | |
| HN1997000097A (es) | Piridinas condensadas con heterociclicos | |
| HN1998000115A (es) | Formas de dosificación farmacéuticas sólidas | |
| HN1998000118A (es) | 2 - aminopiridinas que contienen sustituyentes de anillos condensados. | |
| HN1997000090A (es) | Compuestos de piridilpirrol | |
| HN1998000106A (es) | Composiciones parenterales de alatroflaxacino | |
| HN1998000199A (es) | Agentes terapeuticos | |
| CO4230021A1 (es) | Glicosidos esteroideos, procedimientos de uso de los mismos como agentes hipocolesterolemicos y agentes antiateroscle- roticos en mamiferos. | |
| HN1998000045A (es) | Composiciones farmaceuticas | |
| MX9704683A (es) | Inhibidores de la escualeno sintetasa. | |
| HN1998000091A (es) | Inhibidores de la farnesil transferasa tratamiento del cancer. | |
| HN1998000102A (es) | Composiciones solubilizadas de sertralina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 720597 Country of ref document: ES |